Boston Scientific Corporation (NYSE:BSX) is one of the best mid-cap growth stocks to buy right now. On January 16, ...

Penumbra is expected to give Boston Scientific more of a presence in the vascular surgery market, with little overlap between ...

Boston Scientific has initiated the limited market release of the Seismiq intravascular lithotripsy (IVL) system, marking the ...

Boston Scientific has told customers to stop using certain stents linked to three deaths, the Food and Drug Administration ...

Delving into the details, we found 47% of traders were bullish, while 47% showed bearish tendencies. Out of all the trades we ...

This week's Medtech in a Minute features news about Boston Scientific and a potentially dangerous chemical used in IV bags ...

Penumbra’s stock was up about 12% after the deal was announced Thursday morning.

Boston Scientific is planning a new 300,000-square-foot lab and office building in Maple Grove, expanding its Arbor Lakes ...

By Mariam Sunny and Mrinalika Roy Jan 15 (Reuters) - Boston Scientific agreed to buy medtech firm Penumbra in a $14.5 billion ...

Boston Scientific said it will pay $374 a share in cash and stock for Penumbra, which makes products to remove blood clots ...

The Axios stent system is designed for endoscopic ultrasound-guided transluminal drainage of symptomatic pancreatic ...

This recent drop highlights revived worries regarding the initial earnings dilution stemming from its Penumbra ...